We found an increased expression of ANXA1 in skeletal muscle in GDM and increased levels of ANXA1 in serum has been reported in obesity-related type 2 diabetes mellitus [53]. Here, ANXA1 is linked to obesity due to melanocortin 4 receptor deficiency.